Incidence of Infusion Reactions and Clinical Effectiveness of Intravenous Golimumab Versus Infliximab in Patients with Rheumatoid Arthritis: The Real-World AWARE Study

OBJECTIVE: Evaluate tolerability and effectiveness of golimumab-IV versus infliximab in patients with rheumatoid arthritis (RA) in a real-world setting. METHODS: AWARE, a prospective, real-world, pragmatic, observational, multicenter, phase 4 study, enrolled RA patients when initiating golimumab-IV...

Descripción completa

Detalles Bibliográficos
Autores principales: Curtis, Jeffrey R., Chakravarty, Soumya D., Black, Shawn, Kafka, Shelly, Xu, Stephen, Langholff, Wayne, Parenti, Dennis, Greenspan, Andrew, Schwartzman, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572298/
https://www.ncbi.nlm.nih.gov/pubmed/34417735
http://dx.doi.org/10.1007/s40744-021-00354-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572298/
https://www.ncbi.nlm.nih.gov/pubmed/34417735
http://dx.doi.org/10.1007/s40744-021-00354-4

Ejemplares similares